- Home
- PAVS vs CTSO Comparison
PAVS vs CTSO Comparison
Compare PAVS & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- CTSO
- Stock Information
- Founded
- PAVS 2004
- CTSO 1997
- Country
- PAVS United States
- CTSO United States
- Employees
- PAVS N/A
- CTSO 149
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- CTSO Medical/Dental Instruments
- Sector
- PAVS Health Care
- CTSO Health Care
- Exchange
- PAVS Nasdaq
- CTSO Nasdaq
- Market Cap
- PAVS 45.1M
- CTSO 49.7M
- IPO Year
- PAVS 2019
- CTSO N/A
- Fundamental
- Price
- PAVS $1.05
- CTSO $0.80
- Analyst Decision
- PAVS
- CTSO Buy
- Analyst Count
- PAVS 0
- CTSO 2
- Target Price
- PAVS N/A
- CTSO $5.38
- AVG Volume (30 Days)
- PAVS 717.1K
- CTSO 140.8K
- Earning Date
- PAVS 08-04-2025
- CTSO 11-13-2025
- Dividend Yield
- PAVS N/A
- CTSO N/A
- EPS Growth
- PAVS N/A
- CTSO N/A
- EPS
- PAVS N/A
- CTSO N/A
- Revenue
- PAVS $71,542.00
- CTSO $36,979,520.00
- Revenue This Year
- PAVS N/A
- CTSO $11.93
- Revenue Next Year
- PAVS N/A
- CTSO $21.22
- P/E Ratio
- PAVS N/A
- CTSO N/A
- Revenue Growth
- PAVS N/A
- CTSO 23.89
- 52 Week Low
- PAVS $0.43
- CTSO $0.60
- 52 Week High
- PAVS $1.50
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- PAVS 75.38
- CTSO 56.90
- Support Level
- PAVS $0.56
- CTSO $0.60
- Resistance Level
- PAVS $0.74
- CTSO $0.85
- Average True Range (ATR)
- PAVS 0.13
- CTSO 0.08
- MACD
- PAVS 0.05
- CTSO 0.03
- Stochastic Oscillator
- PAVS 81.82
- CTSO 88.00
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.